Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplastic Cells, Circulating | 6 | 2016 | 946 | 0.950 |
Why?
|
Uniparental Disomy | 1 | 2024 | 45 | 0.940 |
Why?
|
Pedigree | 5 | 2024 | 4542 | 0.910 |
Why?
|
Calpain | 1 | 2024 | 146 | 0.890 |
Why?
|
Prader-Willi Syndrome | 1 | 2024 | 78 | 0.880 |
Why?
|
Germ-Line Mutation | 7 | 2024 | 1858 | 0.880 |
Why?
|
Ataxia Telangiectasia | 1 | 2024 | 107 | 0.880 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2024 | 361 | 0.840 |
Why?
|
von Hippel-Lindau Disease | 1 | 2021 | 151 | 0.710 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2024 | 1085 | 0.700 |
Why?
|
Genes, APC | 1 | 2020 | 145 | 0.700 |
Why?
|
Magnetic Resonance Spectroscopy | 4 | 2013 | 3769 | 0.670 |
Why?
|
Carcinoma, Lobular | 1 | 2024 | 481 | 0.670 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2020 | 218 | 0.640 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2020 | 339 | 0.550 |
Why?
|
Developmental Disabilities | 1 | 2024 | 1509 | 0.500 |
Why?
|
Miniaturization | 2 | 2013 | 153 | 0.440 |
Why?
|
Magnetite Nanoparticles | 2 | 2013 | 318 | 0.400 |
Why?
|
Ferric Compounds | 1 | 2013 | 378 | 0.390 |
Why?
|
Breast Neoplasms | 5 | 2024 | 21019 | 0.380 |
Why?
|
Genetic Predisposition to Disease | 5 | 2024 | 17904 | 0.320 |
Why?
|
Nucleic Acid Hybridization | 2 | 2007 | 1302 | 0.310 |
Why?
|
Genomics | 7 | 2024 | 5821 | 0.300 |
Why?
|
Heterozygote | 2 | 2024 | 2787 | 0.290 |
Why?
|
Thyroid Neoplasms | 1 | 2020 | 2332 | 0.290 |
Why?
|
Metaphase | 1 | 2007 | 145 | 0.280 |
Why?
|
Genetic Testing | 4 | 2024 | 3537 | 0.260 |
Why?
|
Melanoma | 2 | 2022 | 5709 | 0.250 |
Why?
|
Antigens, Neoplasm | 2 | 2016 | 1993 | 0.230 |
Why?
|
Fumarate Hydratase | 1 | 2024 | 52 | 0.230 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2006 | 330 | 0.220 |
Why?
|
Codon, Nonsense | 1 | 2024 | 285 | 0.210 |
Why?
|
Laboratories | 2 | 2016 | 458 | 0.210 |
Why?
|
Sequence Analysis, DNA | 4 | 2017 | 4740 | 0.200 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5821 | 0.200 |
Why?
|
Muscular Dystrophies | 1 | 2024 | 390 | 0.200 |
Why?
|
Nanoparticles | 1 | 2013 | 1958 | 0.200 |
Why?
|
Chromosome Aberrations | 1 | 2007 | 1768 | 0.180 |
Why?
|
Phenotype | 3 | 2024 | 16592 | 0.170 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2020 | 181 | 0.170 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2022 | 259 | 0.170 |
Why?
|
Leiomyoma | 1 | 2024 | 636 | 0.160 |
Why?
|
Genetic Counseling | 2 | 2024 | 627 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2020 | 225 | 0.160 |
Why?
|
Muscle Proteins | 1 | 2024 | 1154 | 0.160 |
Why?
|
Incidental Findings | 3 | 2018 | 697 | 0.160 |
Why?
|
Gene Expression Profiling | 4 | 2018 | 9420 | 0.150 |
Why?
|
Disclosure | 3 | 2018 | 748 | 0.150 |
Why?
|
Oncogenes | 1 | 2024 | 1222 | 0.150 |
Why?
|
Chromosome Mapping | 1 | 2006 | 4615 | 0.150 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3779 | 0.140 |
Why?
|
Lung Neoplasms | 4 | 2017 | 13381 | 0.140 |
Why?
|
Female | 16 | 2024 | 392705 | 0.140 |
Why?
|
Humans | 30 | 2024 | 761596 | 0.140 |
Why?
|
Databases, Genetic | 3 | 2022 | 1742 | 0.140 |
Why?
|
Germ Cells | 1 | 2020 | 634 | 0.140 |
Why?
|
Point-of-Care Systems | 2 | 2016 | 1213 | 0.130 |
Why?
|
Genome, Human | 2 | 2016 | 4425 | 0.130 |
Why?
|
Aged, 80 and over | 6 | 2021 | 58984 | 0.130 |
Why?
|
Neoplasms | 3 | 2013 | 22173 | 0.120 |
Why?
|
Uterine Neoplasms | 1 | 2024 | 1420 | 0.120 |
Why?
|
Thyroidectomy | 1 | 2020 | 908 | 0.120 |
Why?
|
Lung | 1 | 2013 | 10002 | 0.120 |
Why?
|
Quantum Dots | 2 | 2006 | 167 | 0.120 |
Why?
|
Middle Aged | 9 | 2024 | 220921 | 0.110 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2022 | 3639 | 0.110 |
Why?
|
Adult | 10 | 2024 | 221210 | 0.110 |
Why?
|
Melanocytes | 1 | 2016 | 509 | 0.110 |
Why?
|
Click Chemistry | 1 | 2013 | 95 | 0.110 |
Why?
|
Gold | 2 | 2008 | 482 | 0.110 |
Why?
|
Genetic Variation | 2 | 2018 | 6567 | 0.100 |
Why?
|
Mutation | 3 | 2024 | 30053 | 0.090 |
Why?
|
Software | 2 | 2022 | 4434 | 0.090 |
Why?
|
Male | 9 | 2024 | 360846 | 0.090 |
Why?
|
Cell Line, Tumor | 4 | 2016 | 16990 | 0.080 |
Why?
|
Adenocarcinoma | 2 | 2017 | 6345 | 0.080 |
Why?
|
Nanotubes | 1 | 2008 | 82 | 0.070 |
Why?
|
Microdissection | 1 | 2007 | 151 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2018 | 1728 | 0.070 |
Why?
|
Biosensing Techniques | 1 | 2012 | 650 | 0.070 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2012 | 803 | 0.060 |
Why?
|
Tissue Array Analysis | 1 | 2007 | 550 | 0.060 |
Why?
|
Keratins | 1 | 2006 | 498 | 0.060 |
Why?
|
Chromosomes, Human | 1 | 2007 | 441 | 0.060 |
Why?
|
Paraffin Embedding | 1 | 2006 | 302 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2016 | 2539 | 0.060 |
Why?
|
Child | 2 | 2024 | 80158 | 0.060 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2006 | 421 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14665 | 0.060 |
Why?
|
Cytological Techniques | 1 | 2006 | 218 | 0.060 |
Why?
|
Leiomyomatosis | 1 | 2024 | 69 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2018 | 8554 | 0.060 |
Why?
|
Microarray Analysis | 1 | 2006 | 750 | 0.060 |
Why?
|
Metal Nanoparticles | 1 | 2008 | 399 | 0.050 |
Why?
|
Lasers | 1 | 2007 | 952 | 0.050 |
Why?
|
Neoplasm Transplantation | 1 | 2006 | 2016 | 0.050 |
Why?
|
Mitosis | 1 | 2007 | 1188 | 0.050 |
Why?
|
Cadherins | 1 | 2006 | 903 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6965 | 0.050 |
Why?
|
DNA, Neoplasm | 1 | 2007 | 1745 | 0.050 |
Why?
|
Mice, SCID | 1 | 2006 | 2626 | 0.050 |
Why?
|
Database Management Systems | 1 | 2022 | 257 | 0.050 |
Why?
|
Biopsy | 1 | 2013 | 6766 | 0.050 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2007 | 2510 | 0.050 |
Why?
|
Nanostructures | 1 | 2006 | 552 | 0.050 |
Why?
|
Biomedical Research | 1 | 2016 | 3429 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 5368 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4576 | 0.040 |
Why?
|
Genetic Markers | 1 | 2006 | 2601 | 0.040 |
Why?
|
Neoplasm Invasiveness | 1 | 2007 | 3597 | 0.040 |
Why?
|
Transplantation, Heterologous | 1 | 2006 | 2386 | 0.040 |
Why?
|
Child, Preschool | 1 | 2020 | 42232 | 0.040 |
Why?
|
Aged | 4 | 2018 | 169310 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 851 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 6938 | 0.030 |
Why?
|
Adolescent | 1 | 2024 | 88326 | 0.030 |
Why?
|
BRCA1 Protein | 1 | 2022 | 1158 | 0.030 |
Why?
|
Intention | 1 | 2018 | 347 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2016 | 4915 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2016 | 957 | 0.030 |
Why?
|
Signal Transduction | 1 | 2016 | 23447 | 0.030 |
Why?
|
Cyclooctanes | 1 | 2013 | 35 | 0.030 |
Why?
|
Research Report | 1 | 2016 | 367 | 0.030 |
Why?
|
Sample Size | 1 | 2016 | 841 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2006 | 3397 | 0.030 |
Why?
|
Prospective Studies | 1 | 2017 | 54423 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2007 | 12794 | 0.020 |
Why?
|
Patients | 1 | 2018 | 907 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2016 | 1246 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 495 | 0.020 |
Why?
|
Family | 1 | 2022 | 3195 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2016 | 1118 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1486 | 0.020 |
Why?
|
Cohort Studies | 1 | 2013 | 41495 | 0.020 |
Why?
|
HeLa Cells | 2 | 2008 | 3094 | 0.020 |
Why?
|
Computational Biology | 1 | 2022 | 3517 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2021 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 11904 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2016 | 1386 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1745 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2046 | 0.020 |
Why?
|
Information Dissemination | 1 | 2016 | 1126 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2006 | 22176 | 0.020 |
Why?
|
Genotype | 1 | 2022 | 12990 | 0.020 |
Why?
|
Young Adult | 1 | 2013 | 59260 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2057 | 0.020 |
Why?
|
Cell Separation | 1 | 2012 | 1720 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2691 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2024 | 80647 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2008 | 575 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2008 | 695 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2006 | 361 | 0.020 |
Why?
|
Health Care Costs | 1 | 2018 | 3242 | 0.020 |
Why?
|
Antibodies | 1 | 2013 | 2418 | 0.020 |
Why?
|
Surface Properties | 1 | 2008 | 1161 | 0.010 |
Why?
|
Molecular Conformation | 1 | 2006 | 544 | 0.010 |
Why?
|
Health Personnel | 1 | 2018 | 3335 | 0.010 |
Why?
|
Transferrin | 1 | 2006 | 283 | 0.010 |
Why?
|
Decision Making | 1 | 2018 | 3929 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20100 | 0.010 |
Why?
|
Time Factors | 1 | 2006 | 39969 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4016 | 0.010 |
Why?
|
Particle Size | 1 | 2006 | 1648 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2006 | 1606 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15733 | 0.010 |
Why?
|
Cytoplasm | 1 | 2006 | 1510 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2013 | 3617 | 0.010 |
Why?
|
Mice | 1 | 2006 | 81539 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7391 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2006 | 2417 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2006 | 1903 | 0.010 |
Why?
|
Animals | 1 | 2006 | 168475 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2006 | 3530 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36426 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2006 | 9177 | 0.000 |
Why?
|
United States | 1 | 2016 | 72340 | 0.000 |
Why?
|
Concepts
(176)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(68)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_